Bronchiolitis Obliterans (BO) Recruiting Phase 2 Trials for Cyclosporine (DB00091)

Also known as: Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome (BOS) / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0116742 (Bronchiolitis Obliterans (BO))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04107675A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell TransplantTreatment